Page last updated: 2024-11-02

1,7-dimethylxanthine and ALS - Amyotrophic Lateral Sclerosis

1,7-dimethylxanthine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Research Excerpts

ExcerptRelevanceReference
"Riluzole clearance was estimated from serum drug concentration measurements followed by Bayesian fitting."5.33Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis. ( Groeneveld, GJ; Guchelaar, HJ; Kalmijn, S; Spieksma, M; van den Berg, LH; van Kan, HJ, 2005)
"Riluzole clearance was estimated from serum drug concentration measurements followed by Bayesian fitting."1.33Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis. ( Groeneveld, GJ; Guchelaar, HJ; Kalmijn, S; Spieksma, M; van den Berg, LH; van Kan, HJ, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Kan, HJ1
Groeneveld, GJ1
Kalmijn, S1
Spieksma, M1
van den Berg, LH1
Guchelaar, HJ1

Other Studies

1 other study available for 1,7-dimethylxanthine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.
    British journal of clinical pharmacology, 2005, Volume: 59, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Amyotrophic Lateral Sclerosis; Anticonvulsants; Caffe

2005